1,153
Views
4
CrossRef citations to date
0
Altmetric
Articles

Evaluation of the potential nephrotoxicity and mechanism in rats after long-term exposure to the traditional Tibetan medicine tsothel

, , , , , & show all
Pages 678-690 | Received 29 Apr 2018, Accepted 23 Oct 2018, Published online: 17 Dec 2018

References

  • AbdulHameed MD, Ippolito DL, Stallings JD, Wallqvist A. 2016. Mining kidney toxicogenomic data by using gene co-expression modules. BMC Genomics. 17:1–17.
  • Ashhab Y, Alian A, Polliack A, Panet A, Ben Yehuda D. 2001. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett. 495:56–60.
  • Bach RD, Weibel AT. 1976. Nuclear magnetic resonance studies on anion-exchange reactions of alkylmercury mercaptides. J Am Chem Soc. 98:6241–6249.
  • Bonventre JV. 2008. Kidney injury molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl. 241:78–83.
  • Carocci A, Rovito N, Sinicropi MS, Genchi G. 2014. Mercury toxicity and neurodegenerative effects. Rev Environ Contam Toxicol. 229:1–18.
  • Chan J, Huang ZY, Merrifield ME, Salgado MT, Stillman MJ. 2002. Studies of metal binding reactions in metallothioneins by spectroscopic, molecular biology, and molecular modelling techniques. Coord Chem Rev. 233–234:319–339.
  • Chen ZJ, Pu XL, Li WH, Wu KZ, Lan GW, Cui J. 2011. Influence of Tibetan medicine Zuota on the life of fruit fly. Shi Zhen Guo Yi Guo Yao. 22: 422–423.
  • Cooper K, Noller B, Connell D, Yu J, Sadler R, Olszowy H, Golding G, Tinggi U, Moore MR, Myers S. 2007. Public health risks from heavy metals and metalloids present in traditional Chinese medicines. J Toxicol Environ Health. Part AA. 70:1694–1699.
  • Dabrio M, Rodríguez AR, Bordin G, Bebianno MJ, De Ley M, Sestáková I, Vasák M, Nordberg M. 2002. Recent developments in quantification methods for metallothionein. J Inorg Biochem. 88:123–134.
  • de Ceaurriz J, Payan JP, Morel G, Brondeau MT. 1994. Role of extracellular glutathione and gamma-glutamyltranspeptidase in the disposition and kidney toxicity of inorganic mercury in rats. J Appl Toxicol. 14:201–206.
  • Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, et al. 2010. Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat Biotechnol. 28:463–469.
  • Dou G. 2005. Analysing the toxicity of Tibetan pharmacist-prepared medicine in ‘‘Zuo Tai’’ as well as its compatibility. J Qinghai Junior Teachers' College (Education Science.). 4:72–75.
  • Duo J, Chu C. 2013. Mechanism and processing of Zuota. Zhongguo Min Zu Yi Yao Za Zhi. 7:11–12.
  • Endl E, Gerdes J. 2000. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res. 257:231–237.
  • Ernst E. 2002. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci. 23:136–139.
  • Gegg ME, Beltran B, Salas-Pino S, Bolanos JP, Clark JB, Moncada S, Heales SJ. 2003. Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?. J Neurochem. 86:228–237.
  • He YM, Zeng Y, Zhang Y. 2006. Research on the development of Tibetan medicine “zuo ta”. Zhongguo Min Zu Yi Yao Za Zhi. 1:39–41.
  • Herman-Antosiewicz A, Singh SV. 2004. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutation Res. 555:121–131.
  • Huang HB, Wang QZ, Wang XW, Feng X, Sun H, Li WY, Wang M. 2013. Overview of current research on Tibetan medicine “Zuotai”. Zhongguo Zhong Yao Za Zhi. 38:2886–2888.
  • Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 273:4135–4142.
  • Jan AT, Ali A, Haq Q. 2011. Glutathione as an antioxidant in inorganic mercury induced nephrotoxicity. J Postgrad Med. 57:72–77.
  • Jiang AN, Zhang CG, Wang JH, Li ZG, Cheng F, Xue X, Liu ZP. 2009. Pharmacodynamics study of "Zuo Tai". Shi Zhen Guo Yi Guo Yao. 20:3–5.
  • Jurczuk M, Moniuszko-Jakoniuk J, Brzóska MM. 2006. Involvement of some low-molecular thiols in the peroxidative mechanisms of lead and ethanol action on rat liver and kidney. Toxicology. 219:11–21.
  • Kan ZB. 2013. An introduction of Zuotai in Tibetan patent medicine. Zhongguo Zhong Yao Za Zhi. 38:1621–1623.
  • Klaassen CD, Liu J, Choudhuri S. 1999. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol. 39:267–294.
  • Klaassen CD. 2006. Heavy metals and heavy-metal antagonists. In: Mercurials. New York: McGraw-Hill; p. 1753–1755.
  • Kromidas L, Trombetta LD, Jamall IS. 1990. The protective effects of glutathione against methylmercury cytotoxicity. Toxicol Lett. 51:67–80.
  • Lee YM, Lee KW, Park H, Park HG, Raisuddin S, Ahn IY, Lee JS. 2007. Sequence, biochemical characteristics and expression of a novel Sigma-class of glutathione S-transferase from the intertidal copepod, Tigriopus japonicus with a possible role in antioxidant defense. Chemosphere. 69:893–902.
  • Li WC, Ralphs KL, Tosh D. 2010. Isolation and culture of adult mouse hepatocytes. Methods Mol Biol (Clifton, N.J.). 633:185–196.
  • Li CR, Zhou Z, Zhu D, Sun YN, Dai JM, Wang SQ. 2007. Protective effect of paeoniflorin on irradiation-induced cell damage involved in modulation of reactive oxygen species and the mitogen-activated protein kinases. Int J Biochem & Cell Biol. 39:426–438.
  • Liang AH, Wang JH, Xue BY, Li CY, Liu T, Zhao Y, Cao C, Yi Y. 2009. Study on hepatotoxicity and nephrotoxicity of cinnabar in rats. Zhongguo Zhong Yao Za Zhi. 34:312–318.
  • Liang AH, Xu YJ, Shang MF. 2005. Analysis of adverse effects of cinnabar. Zhongguo Zhong Yao Za Zhi. 30:1809–1811.
  • Li XY, Feng WL, Ma QS, Zhu JB, Nima CR, Geri L. 2010. Preliminary study on the absorption and excretion of mercury in Tibetan medicine Zuotai in rats. Shi Zhen Guo Yi Guo Yao. 21:290–292.
  • Li B, Li Y-D, Yang Z, Chen Y, Liu P, Liu Y, Zhang Z-F, Lv L-Y, Zhang J-Z, Zeng R, et al. 2016. In vitro toxicity evaluations of Tibetan medicine Zuota from four institutions. Drug Chem Toxicol. 39:174–181.
  • Liu J, Shi JZ, Yu LM, Goyer RA, Waalkes MP. 2008. Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? Exp Biol Med (Maywood, N.J.). 233:810–817.
  • Liu YC, Zheng W, Kang JQ, Cheng YB, Jin YL. 2011. Adverse effects of chronic mercury vapor exposure on renal function of human. Huan Jing Yu Jiang Kang Za Zhi. 28:242–244.
  • Li C, Wang DP, Duo J, Duojie LD, Chen XM, Du YZ, Yang HX, Zheng ZY, Yu MJ, Wei LX. 2014. Study on safety of Tibetan medicine Zuotai and preliminary study on clinical safety of its compound Dangzuo. Zhongguo Zhong Yao Za Zhi. 39:2573–2582.
  • Llobet JM, Falcó G, Casas C, Teixidó A, Domingo JL. 2003. Concentrations of arsenic, cadmium, mercury, and lead in common foods and estimated daily intake by children, adolescents, adults, and seniors of Catalonia, Spain. J Agric Food Chem. 51:838–842.
  • Lu YF, Wu Q, Yan JW, Shi JZ, Liu J, Shi JS. 2011. Realgar, cinnabar and An-Gong-Niu-Huang Wan are much less chronically nephrotoxic than common arsenicals and mercurials. Exp Biol Med (Maywood, N.J.). 236:233–239.
  • Lund BO, Miller DM, Woods JS. 1993. Studies on Hg(II)-induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem Pharmacol. 45:2017–2024.
  • Luo DS. 2004. New repair jingzhu materia medica. In: Mineral medicine. Shanghai: Shanghai Science and Technology Press; p. 125–127.
  • Mahboob M, Shireen KF, Atkinson A, Khan AT. 2001. Lipid peroxidation and antioxidant enzyme activity in different organs of mice exposed to low level of mercury. J Environ Sci Health B. 36:687–697.
  • Malumbres M, Barbacid M. 2007. Cell cycle kinases in cancer. Curr Opin Genet Dev. 17:60–65.
  • Mao JJ, Desai K. 2009. Metal content in ayurvedic medicines. JAMA. 301:271–272.
  • Prozialeck WC, Edwards JR, Lamar PC, Liu J, Vaidya VS, Bonventre JV. 2009. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Toxicol Appl Pharmacol. 238:306–314.
  • Ramachandran S, Hoban PR, Ichii-Jones F, Pleasants L, Ali-Osman F, Lear JT, Smith AG, Bowers B, Jones PW, Fryer AA, et al. 2000. Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours. Pharmacogenetics. 10:545–556.
  • Roberti di Sarsina P, Ottaviani L, Mella J. 2011. Tibetan medicine: a unique heritage of person-centered medicine. EPMA J. 2:385–389.
  • Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Paquin J, Thuppil V, Kales SN. 2008. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 300:915–923.
  • Satoh M, Nishimura N, Kanayama Y, Naganuma A, Suzuki T, Tohyama C. 1997. Enhanced renal toxicity by inorganic mercury in metallothionein-null mice. J Pharmacol Exp Ther. 283:1529–1533.
  • Sener G, Sehirli AO, Ayanoglu-Dülger G. 2003. Melatonin protects against mercury(II)-induced oxidative tissue damage in rats. Pharmacol & Toxicol. 93:290–296.
  • Shi JZ, Kang F, Wu Q, Lu YF, Liu J, Kang YJ. 2011. Nephrotoxicity of mercuric chloride, methylmercury and cinnabar-containing Zhu-Sha-An-Shen-Wan in rats. Toxicol Lett. 200:194–200.
  • Suo L. 2007. Processing of Zuota. Zhongguo Min Zu Yi Yao Za Zhi. 5:40.
  • Tanaka-Kagawa T, Suzuki M, Naganuma A, Yamanaka N, Imura N. 1998. Strain difference in sensitivity of mice to renal toxicity of inorganic mercury. J Pharmacol Exp Therapeut. 285:335–341.
  • Tang H, Zou P. 2006. A review of developments of kidney injury molecule-1. Guo Ji Jian Yan Yi Xue Za Zhi. 27:719–720.
  • Tchounwou PB, Ayensu WK, Ninashvili N, Sutton D. 2003. Environmental exposure to mercury and its toxicopathologic implications for public health. Environ Toxicol. 18:149–175.
  • Veal EA, Toone WM, Jones N, Morgan BA. 2002. Distinct roles for glutathione S-transferases in the oxidative stress response in Schizosaccharomyces pombe. J Biol Chem. 277:35523–35531.
  • Wang H, Bai J, Chen G, Li W, Xiang R, Su G, Pei Y. 2013. A metabolic profiling analysis of the acute hepatotoxicity and nephrotoxicity of Zhusha Anshen Wan compared with cinnabar in rats using 1H NMR spectroscop. J Ethnopharmacol. 146:572–580.
  • Wei D, Zhang XL, Wang YZ, Yang CX, Chen G. 2010. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J. 55:70–78.
  • Wong SC, Chan AT, Chan JK, Lo YM. 2006. Nuclear beta-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form. J Clin Pathol. 59:387–392.
  • Woods JS, Calas CA, Aicher LD, Robinson BH, Mailer C. 1990. Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide. Mol Pharmacol. 38:253–260.
  • Xiong JH, Zhao J, Xu S, Gao L. 2010. Retionol binding protein on the diagnosis of early renal damage. Yi Xue Li Lun Yu Shi Jian. 23:905–907.
  • Xu X, Tang LD. 2010. Official use of seven new biomarkers of renal injury approved by FDA and EMEA. Yao Wu Ping Jia Yan Jiu. 33:347–350.
  • Yang BS. 2004. The pharmacology and safety of mercury in Tibetan medicine Zuota. Tibetan Res. 1:74–80.
  • Yutuo Y. 1987. Medical canon in four sections. Shanghai: Shanghai Science and Technology Press; p. 238–240.
  • Zalups RK. 2000. Molecular interactions with mercury in the kidney. Pharmacol Rev. 52:113–143.
  • Zalups RK, Lash LH. 1994. Advances in understanding the renal transport and toxicity of mercury. J Toxicol Environ Health. 42:1–44.
  • Zeng Y, He YM, Liu Y, Wang Z, Zhang Y. 2005. Pharmacological research of "Zuo Ta" on the central nervous system. Si Chuan Zhong Yi. 23: 33–34.
  • Zhang GY, Wang DP, Li C, Zhu HM, Wei LX, Du YZ. 2012. The chronic accumulation of mercury in Tibetan medicine Zuotai (gTsothal.). Shi Zhen Guo Yi Guo Yao. 23:2146–2147.
  • Zhou Y, Li Z, Tang F, Ge R. 2016. Proteomics annotate therapeutic properties of a traditonal Tibetan medicine - Tsantan Sumtang targeting and regulating multiple perturbed pathways. J Ethnopharmacol. 181:108–117.
  • Zhou X, Zeng K, Wang Q, Yang X, Wang K. 2010. In vitro studies on dissolved substance of cinnabar: chemical species and biological properties. J Ethnopharmacol. 131:196–202.
  • Zhou X, Wang Q, Yang X. 2009. Progresses on mechanisms of pharmacological and toxicological effects of cinnabar. Zhongguo Zhong Yao Za Zhi. 34:2843–2847.
  • Zhu G. 2006. Medicine & pharmacy of Chinese minorities. Beiijng: Chinese Medical Science Press; p. 337–338.
  • Zuskin E, Lipozencić J, Pucarin-Cvetković J, Mustajbegović J, Schachter N, Mučić-Pučić B, Neralić-Meniga I. 2008. Ancient medicine-a review. Acta Dermatovenerologica Croatica. 16:149–157.